Tadamitsu Kishimoto

Active 1973–2025

Also published as
Tadamitsu Kishimoto†
286
Papers
96,885
Citations
168
h-index
284
i10-index

Citations

Citations per year for Tadamitsu Kishimoto1971: 1 citations1973: 1 citations1974: 3 citations1975: 4 citations1976: 7 citations1977: 2 citations1978: 6 citations1979: 6 citations1980: 12 citations1981: 5 citations1982: 8 citations1983: 19 citations1984: 19 citations1985: 24 citations1986: 36 citations1987: 96 citations1988: 244 citations1989: 438 citations1990: 514 citations1991: 464 citations1992: 531 citations1993: 606 citations1994: 873 citations1995: 749 citations1996: 819 citations1997: 877 citations1998: 1,046 citations1999: 1,066 citations2000: 1,214 citations2001: 1,009 citations2002: 1,178 citations2003: 1,062 citations2004: 958 citations2005: 938 citations2006: 893 citations2007: 877 citations2008: 854 citations2009: 798 citations2010: 949 citations2011: 824 citations2012: 822 citations2013: 718 citations2014: 777 citations2015: 603 citations2016: 542 citations2017: 481 citations2018: 556 citations2019: 1,440 citations2020: 1,813 citations2021: 1,747 citations2022: 1,300 citations2023: 816 citations2024: 1,276 citations2025: 533 citations2026: 28 citations1972: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,800 citing papers, 30.7% of this breakdownChina: 2,590 citing papers, 9% of this breakdownJapan: 2,574 citing papers, 9% of this breakdownGermany: 1,909 citing papers, 6.6% of this breakdownUnited Kingdom: 1,742 citing papers, 6.1% of this breakdownFrance: 1,058 citing papers, 3.7% of this breakdownItaly: 1,013 citing papers, 3.5% of this breakdownCanada: 867 citing papers, 3% of this breakdownAustralia: 782 citing papers, 2.7% of this breakdownNetherlands: 553 citing papers, 1.9% of this breakdownSpain: 521 citing papers, 1.8% of this breakdownSwitzerland: 510 citing papers, 1.8% of this breakdown
0%30.7%Other 20.2%

Fields

  • Medicine51.2%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Immunology and Microbiology19.1%
  • Neuroscience5.8%
  • Agricultural and Biological Sciences0.7%
  • Environmental Science0.6%
  • Other2.7%

Topics

  • Cytokine Signaling Pathways and Interactions5.4%
  • Immune Cell Function and Interaction4.1%
  • T-cell and B-cell Immunology3.3%
  • Immune Response and Inflammation3%
  • Immunotherapy and Immune Responses2.3%
  • Chemokine receptors and signaling1.7%
  • Other80.2%

Coauthors

All papers

Open in search
  1. IL‐6: Regulator of Treg/Th17 balance

    Authors: , - European Journal of Immunology 2010 cited by 1,572

  2. Translating IL-6 biology into effective treatments

    Authors: , , , , , - Nature Reviews Rheumatology 2020 cited by 697

  3. Targeting Interleukin-6 Signaling in Clinic

    Authors: , , , - Immunity 2019 cited by 894

  4. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

    Authors: , - Experimental & Molecular Medicine 2021 cited by 370

  5. Historical overview of the interleukin-6 family cytokine

    Authors: , , , - The Journal of Experimental Medicine 2020 cited by 356

  6. Interleukin (IL-6) Immunotherapy

    Authors: , , - Cold Spring Harbor Perspectives in Biology 2017 cited by 413

  7. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 668

  8. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 334

  9. IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19

    Authors: , - Annual Review of Immunology 2022 cited by 128

  10. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2000 cited by 1,289

  11. Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm

    Authors: , , - Immunotherapy 2016 cited by 737

  12. Essential role of Stat6 in IL-4 signalling

    Authors: , , , , , , , , , - Nature 1996 cited by 1,577

  13. Impaired immune and acute-phase responses in interleukin-6-deficient mice

    Authors: , , , , , , , , - Nature 1994 cited by 1,798

  14. INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology

    Authors: - Annual Review of Immunology 2004 cited by 1,018

  15. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 1,335

  16. TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

    Authors: , , , , , , , , , , , , , , , , , - Immunity 2004 cited by 719

  17. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 257

  18. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

    Authors: , , , , , , , , , , , , , , , - Nature 1986 cited by 2,166

  19. TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a

    Authors: , , , , , , , , , , , - Nucleic Acids Research 2017 cited by 221

  20. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses

    Authors: , , , , , , , - The Journal of Experimental Medicine 2009 cited by 405

  21. Regulation of IL-6 in Immunity and Diseases

    Authors: , , , - Advances in experimental medicine and biology 2016 cited by 225

  22. Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2005 cited by 750

  23. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

    Authors: , , , , , , , - Cell 1989 cited by 1,412

  24. The role and therapeutic targeting of IL-6 in rheumatoid arthritis

    Authors: , , - Expert Review of Clinical Immunology 2017 cited by 230